Innovative Product Avancen MOD Corporation has developed the world’s first oral PCA system, offering a unique solution for medication delivery that enhances patient comfort and safety, presenting a compelling case for hospitals seeking advanced pain management options.

COVID-19 Response The recent launch of their oral medication delivery system specifically facilitates self-administration for COVID-19 patients outside intensive care, indicating a market opportunity within hospitals managing infectious diseases and needing scalable, autonomous medication solutions.

Healthcare Focus Serving hospital and healthcare facilities, Avancen MOD’s technology aligns with the growing demand for innovative, patient-centric medical devices, making them a potential partner for healthcare providers investing in outpatient and non-ICU care enhancements.

Growth Potential With revenues estimated between one and ten million dollars and a specialized product line, Avancen MOD Corporation is positioned for targeted expansion into hospitals and clinics seeking cutting-edge medication management systems.

Tech Stack Leverage Utilizing cloud-based and modern web technologies, the company demonstrates a tech-savvy approach that can be appealing when partnering with institutional clients looking for reliable, innovative, and scalable digital solutions in healthcare environments.